Indication
Topotecan is indicated for the treatment of patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy.
Loading your page…
Loading your page…
Ovarian Neoplasms
Marketing Authorisation Holder: Beecham Group plc
EMA Authorisation: 15/04/1997
INN: topotecan
AI Drug & Interaction Analysis
Free account required
Ask Osler about Evotopin: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.